{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T13:09:38Z","timestamp":1787836178757,"version":"build-2784847793"},"reference-count":53,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T00:00:00Z","timestamp":1759104000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Dengue viruses belong to the genus Flavivirus and consist of a serocomplex of four serotypes (DENV-1, DENV-2, DENV-3, and DENV-4). As arthropod-borne viruses (arboviruses), their transmission is mediated primarily by the vector Aedes aegypti. Antiviral immune response is one of the most crucial factors influencing the progression from uncomplicated to severe dengue virus (DENV) infection. Two types of antibody responses are elicited during a DENV infection: one specific to the infecting serotype (serotype-specific or homotypic response) and another that cross-reacts with other serotypes (cross-reactive or heterotypic response). Both responses play roles in the protection against and in the induction of immunopathogenesis of DENV disease. In the case of the humoral immune response, the balance between protective and pathogenic effects mediated by antibodies (antibody-dependent enhancement, ADE) is highly dynamic and influenced by multiple factors. Although many downstream effector mechanisms depend on antibody recognition by Fc-gamma receptors (Fc\u03b3Rs) present on immune effector cells, this interaction is traditionally not considered when evaluating antibody properties. Specifically, Fc\u03b3RIIIA has been implicated in both protection and immunopathogenesis of virus infection. To assess its role within the humoral immune response to DENV, we took advantage of Fc\u03b3RIIIA-CD3\u03b6 reporter cells and tested receptor activation by polyclonal sera from individuals with past and acute DENV infections. In addition, the neutralizing capacity and the potential enhancement of infection were analyzed. The Fc\u03b3RIIIA activation assay revealed a humoral profile distinct from neutralization and immunopotentiation, primarily mediated by cross-reactive antibodies. Notably, this profile increases during the post-acute period but disappears within two years after infection. Because these two types of antibodies are found during both the cross-protective and disease-enhancing (immunopotentiation) phases, their exact function in each situation is still not clearly understood. The results of this study provide a valuable measurement of the effector function of anti-DENV antibodies, contributing to the understanding of their role in both protective and disease enhancing courses of DENV infection.<\/jats:p>","DOI":"10.3389\/fimmu.2025.1662138","type":"journal-article","created":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T05:26:33Z","timestamp":1759123593000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Fc\u03b3RIIIA -activating antibodies in dengue virus infection reveals a distinct transient cross-reactive profile"],"prefix":"10.3389","volume":"16","author":[{"given":"Claudio","family":"Soto-Garita","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatiana","family":"Murillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hartmut","family":"Hengel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugenia","family":"Corrales-Aguilar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,9,29]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1038\/nature12060","article-title":"The global distribution and burden of dengue","volume":"496","author":"Bhatt","year":"2013","journal-title":"Nature"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2024.1421744","article-title":"Epidemiological, virological and clinical characterization of a Dengue\/Zika outbreak in the Caribbean region of Costa Rica 2017-2018","volume":"14","author":"Soto-Garita","year":"2024","journal-title":"Front Cell Infect Microbiol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jiph.2023.08.001","article-title":"Dengue overview: An updated systemic review","volume":"16","author":"Khan","year":"2023","journal-title":"J Infect Public Health"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(23)02576-X","article-title":"Dengue","volume":"403","author":"Paz-Bailey","year":"2024","journal-title":"Lancet"},{"key":"B5","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/S1567-1348(03)00004-2","article-title":"The origin, emergence and evolutionary genetics of dengue virus","volume":"3","author":"Holmes","year":"2003","journal-title":"Infect Genet Evol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1089\/vbz.2010.0177","article-title":"Virus role during intraepidemic increase in dengue disease severity","volume":"11","author":"Rodriguez-Roche","year":"2011","journal-title":"Vector Borne Zoonotic Dis"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.73.6.4738-4747.1999","article-title":"Dengue virus structural differences that correlate with pathogenesis","volume":"73","author":"Leitmeyer","year":"1999","journal-title":"J Virol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(99)04015-5","article-title":"Failure of secondary infection with American genotype dengue 2 to cause dengue haemorrhagic fever","volume":"354","author":"Watts","year":"1999","journal-title":"Lancet"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-019-0123-x","article-title":"Adaptive immune responses to primary and secondary dengue virus infections","volume":"19","author":"St John","year":"2019","journal-title":"Nat Rev Immunol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"20130414","DOI":"10.1098\/rsif.2013.0414","article-title":"Interactions between serotypes of dengue highlight epidemiological impact of cross-immunity","volume":"10","author":"Reich","year":"2013","journal-title":"J R Soc Interface"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1038\/nri3014","article-title":"Immunity to dengue virus: a tale of original antigenic sin and tropical cytokine storms","volume":"11","author":"Rothman","year":"2011","journal-title":"Nat Rev Immunol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"e1192","DOI":"10.1371\/journal.pone.0001192","article-title":"High pro-inflammatory cytokine secretion and loss of high avidity cross-reactive cytotoxic T-cells during the course of secondary dengue virus infection","volume":"2","author":"Dong","year":"2007","journal-title":"PloS One"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00330-07","article-title":"Differential functional avidity of dengue virus-specific T-cell clones for variant peptides representing heterologous and previously encountered serotypes","volume":"81","author":"Imrie","year":"2007","journal-title":"J Virol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1128\/CVI.00316-10","article-title":"How innate immune mechanisms contribute to antibody-enhanced viral infections","volume":"17","author":"Ubol","year":"2010","journal-title":"Clin Vaccine Immunol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1038\/nm887","article-title":"Original antigenic sin and apoptosis in the pathogenesis of dengue hemorrhagic fever","volume":"9","author":"Mongkolsapaya","year":"2003","journal-title":"Nat Med"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1038\/265739a0","article-title":"Antibody-enhanced dengue virus infection in primate leukocytes","volume":"265","author":"Halstead","year":"1977","journal-title":"Nature"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1126\/science.1185181","article-title":"Cross-reacting antibodies enhance dengue virus infection in humans","volume":"328","author":"Dejnirattisai","year":"2010","journal-title":"Science"},{"key":"B18","doi-asserted-by":"publisher","first-page":"e1004386","DOI":"10.1371\/journal.ppat.1004386","article-title":"Dengue viruses are enhanced by distinct populations of serotype cross-reactive antibodies in human immune sera","volume":"10","author":"de Alwis","year":"2014","journal-title":"PloS Pathog"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1038\/nature14130","article-title":"Recognition determinants of broadly neutralizing human antibodies against dengue viruses","volume":"520","author":"Rouvinski","year":"2015","journal-title":"Nature"},{"key":"B20","doi-asserted-by":"publisher","first-page":"e0006879","DOI":"10.1371\/journal.pntd.0006879","article-title":"Seroprevalence of dengue virus in two districts of Kaohsiung City after the largest dengue outbreak in Taiwan since World War II","volume":"12","author":"Tsai","year":"2018","journal-title":"PloS Negl Trop Dis"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1007\/s002770050396","article-title":"The IgG Fc receptor family","volume":"76","author":"Gessner","year":"1998","journal-title":"Ann Hematol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"eabm3151","DOI":"10.1126\/scitranslmed.abm3151","article-title":"Antibody Fc characteristics and effector functions correlate with protection from symptomatic dengue virus type 3 infection","volume":"14","author":"Dias","year":"2022","journal-title":"Sci Transl Med"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1126\/science.abc7303","article-title":"Antibody fucosylation predicts disease severity in secondary dengue infection","volume":"372","author":"Bournazos","year":"2021","journal-title":"Science"},{"key":"B24","article-title":"Prevalencia de anticuerpos contra virus dengue en el cant\u00f3n de Golfito (2005) y en el Distrito Central de Puntarenas (2005-2006), Costa Rica","volume":"50","author":"Lee-Lui","year":"2008","journal-title":"Acta Med Costarricense"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1128\/jcm.30.3.545-551.1992","article-title":"Rapid detection and typing of dengue viruses from clinical samples by using reverse transcriptase-polymerase chain reaction","volume":"30","author":"Lanciotti","year":"1992","journal-title":"J Clin Microbiol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.jim.2012.09.006","article-title":"A novel assay for detecting virus-specific antibodies triggering activation of Fc\u03b3 receptors","volume":"387","author":"Corrales-Aguilar","year":"2013","journal-title":"J Immunol Methods"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2009.09.098","article-title":"Preclinical and clinical development of YFV 17D-based chimeric vaccines against dengue, West Nile and Japanese encephalitis viruses","volume":"28","author":"Guy","year":"2010","journal-title":"Vaccine"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1007\/s00430-016-0457-y","article-title":"Highly individual patterns of virus-immune IgG effector responses in humans","volume":"205","author":"Corrales-Aguilar","year":"2016","journal-title":"Med Microbiol Immunol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1128\/CVI.00095-09","article-title":"Evaluation of chimeric Japanese encephalitis and dengue viruses for use in diagnostic plaque reduction neutralization tests","volume":"16","author":"Johnson","year":"2009","journal-title":"Clin Vaccine Immunol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1038\/ni.3515","article-title":"Dengue virus sero-cross-reactivity drives antibody-dependent enhancement of infection with zika virus","volume":"17","author":"Dejnirattisai","year":"2016","journal-title":"Nat Immunol"},{"key":"B31","doi-asserted-by":"publisher","first-page":"e65231","DOI":"10.1371\/journal.pone.0065231","article-title":"Dengue virus neutralization in cells expressing fc gamma receptors","volume":"8","author":"Chawla","year":"2013","journal-title":"PloS One"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1016\/j.jviromet.2009.10.026","article-title":"A simple assay system for infection-enhancing and -neutralizing antibodies to dengue type 2 virus using layers of semi-adherent K562 cells","volume":"163","author":"Konishi","year":"2010","journal-title":"J Virol Methods"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1200195","article-title":"Dengue virus neutralizing antibody: a review of targets, cross-reactivity, and antibody-dependent enhancement","volume":"14","author":"Sarker","year":"2023","journal-title":"Front Immunol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofae720","article-title":"Dengue virus structural proteins are expressed on the surface of DENV-infected cells and are a target for antibody-dependent cellular phagocytosis","volume":"12","author":"Waldran","year":"2024","journal-title":"Open Forum Infect Dis"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-018-0157-4","article-title":"Reconstruction of antibody dynamics and infection histories to evaluate dengue risk","volume":"557","author":"Salje","year":"2018","journal-title":"Nature"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.2400447","article-title":"IgG glycosylation: biomarker, functional modulator, and structural component","volume":"213","author":"Radovani","year":"2024","journal-title":"J Immunol"},{"key":"B37","doi-asserted-by":"publisher","first-page":"eabf8654","DOI":"10.1126\/scitranslmed.abf8654","article-title":"High titers and low fucosylation of early human anti\u2013SARS-CoV-2 IgG promote inflammation by alveolar macrophages","volume":"13","author":"Hoepel","year":"2021","journal-title":"Sci Trans Med"},{"key":"B38","doi-asserted-by":"publisher","first-page":"5654","DOI":"10.1038\/s41467-022-32867-z","article-title":"Circulating multimeric immune complexes contribute to immunopathology in COVID-19","volume":"13","author":"Ankerhold","year":"2022","journal-title":"Nat Commun"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-09-179754","article-title":"Specificity and affinity of human Fcgamma receptors and their polymorphic variants for human IgG subclasses","volume":"113","author":"Bruhns","year":"2009","journal-title":"Blood"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1126\/science.aan6836","article-title":"Antibody-dependent enhancement of severe dengue disease in humans","volume":"358","author":"Katzelnick","year":"2017","journal-title":"Science"},{"key":"B41","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1038\/s41467-024-53916-9","article-title":"Dengue virus IgG and neutralizing antibody titers measured with standard and mature viruses are protective","volume":"16","author":"Odio","year":"2025","journal-title":"Nat Commun"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1126\/science.aai8128","article-title":"IgG antibodies to dengue enhanced for Fc\u03b3RIIIA binding determine disease severity","volume":"355","author":"Wang","year":"2017","journal-title":"Science"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1106568108","article-title":"Ligation of Fc gamma receptor IIB inhibits antibody-dependent enhancement of dengue virus infection","volume":"108","author":"Chan","year":"2011","journal-title":"Proc Natl Acad Sci"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.06075-11","article-title":"Rapid and massive virus-specific plasmablast responses during acute dengue virus infection in humans","volume":"86","author":"Wrammert","year":"2012","journal-title":"J Virol"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.15-0199","article-title":"Association of fc\u03b3RIIa polymorphism with clinical outcome of dengue infection: first insight from Pakistan","volume":"93","author":"Mohsin","year":"2015","journal-title":"Am J Trop Med Hyg"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1038\/s41564-023-01421-y","article-title":"Human Fc\u03b3RIIIa activation on splenic macrophages drives dengue pathogenesis in mice","volume":"8","author":"Yamin","year":"2023","journal-title":"Nat Microbiol"},{"key":"B47","doi-asserted-by":"publisher","first-page":"e14182","DOI":"10.15252\/emmm.202114182","article-title":"Detection and functional resolution of soluble immune complexes by an Fc\u03b3R reporter cell panel","volume":"14","author":"Chen","year":"2022","journal-title":"EMBO Mol Med"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1598605","article-title":"Human Fc\u03b3-receptors selectively respond to C-reactive protein isoforms","volume":"16","author":"Henning","year":"2025","journal-title":"Front Immunol"},{"key":"B49","doi-asserted-by":"publisher","first-page":"e1011223","DOI":"10.1371\/journal.ppat.1011223","article-title":"Understanding antibody-dependent enhancement in dengue: Are afucosylated IgG1s a concern","volume":"19","author":"Teo","year":"2023","journal-title":"PloS Pathog"},{"key":"B50","doi-asserted-by":"publisher","first-page":"107642","DOI":"10.1016\/j.celrep.2020.107642","article-title":"Maternal anti-dengue igG fucosylation predicts susceptibility to dengue disease in infants","volume":"31","author":"Thulin","year":"2020","journal-title":"Cell Rep"},{"key":"B51","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1038\/s41598-018-36972-2","article-title":"NK cells activated through antibody-dependent cell cytotoxicity and armed with degranulation\/IFN-\u03b3 Production suppress antibody-dependent enhancement of dengue viral infection","volume":"9","author":"Sun","year":"2019","journal-title":"Sci Rep"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1189\/jlb.0806510","article-title":"The CD14+ CD16+ blood monocytes: their role in infection and inflammation","volume":"81","author":"Ziegler-Heitbrock","year":"2007","journal-title":"J Leukoc Biol"},{"key":"B53","doi-asserted-by":"publisher","first-page":"e2509016122","DOI":"10.1073\/pnas.2509016122","article-title":"Fc\u03b3RIIIa is a noncanonical costimulatory molecule for CD8 T cells","volume":"122","author":"Kao","year":"2025","journal-title":"Proc Natl Acad Sci U S A"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1662138\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T05:26:34Z","timestamp":1759123594000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1662138\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,29]]},"references-count":53,"alternative-id":["10.3389\/fimmu.2025.1662138"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2025.1662138","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,29]]},"article-number":"1662138"}}